• SENSEX 76,617.44
    592.93 (+0.78%)
  • BANKNIFTY 51,348.05
    520.55 (+1.02%)
  • IndusInd Bank
    708.45 1,576.00(%)
  • Kalyan Jewellers
    519.15 794.60(%)
  • Dr Lal Pathlabs
    2,508.00 3,645.00(%)
  • ICICI BLR Growth
    1,003.14 1,001.47(%)
  • Vodafone Idea
    8.33 19.15(%)
  • Bharat Electron
    274.50 204.00(%)
  • Quadrant Future
    605.00 743.45(%)
  • Zomato Ltd
    212.60 304.50(%)
  • SRF
    2,986.25 3,074.95(%)
  • Bengal & Assam
    7,450.00 11,498.90(%)
  • ICICI Bank
    1,338.00 1,372.50(%)
  • Mazagon Dock
    2,610.00 2,929.98(%)
  • Suzlon Energy
    57.74 86.04(%)
  • SpiceJet
    46.10 79.90(%)
  • Dixon Technolog.
    13,485.00 19,149.80(%)
  • Adani Green
    944.95 2,173.65(%)
  • Aegis Logistics
    830.35 1,035.70(%)
  • Hind.Aeronautics
    4,252.00 5,675.00(%)
  • M & M
    2,660.50 3,276.30(%)
  • Nippon ETF Liq.
    999.99 996.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Ind-Swift Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4123.0
  • ISIN : INE788B01028
13.80 1 (4.94%)
  • As on 03 Apr 2025 (EOD)

  • Today’s Low

    13.10

  • Today’s High

    13.80

  • Open

    13.45

  • Perv Close

    13.15

  • 52W Low

    12.46

  • 52W High

    34.70

Key Indicators

  • P/E(TTM)

    1.17

  • Mar.Cap (₹Cr.)

    74.75

  • Div & Yield %

    0.00

  • Book Value(₹)

    -121.57

  • Debt-Equity Ratio

    4.94

  • AGM Date

    02-Apr-2025

  • EPS

    11.89

  • P/E Ratio

    1.17

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    74.75

  • RONW (%)

    -12.54

  • ROCE (%)

    3.39

Score Board

  • Equity (₹ in Cr.)

    10.83

  • BV (₹)

    -121.60

  • Sales( ₹ in Cr.)

    502.25

  • NP (in Cr.)

    -24.16

  • NP Var(%)

    31.0

  • Div%

    0.0

  • CPS (₹)

    0.50

  • EPS (₹)

    -4.50

  • Traded Value (₹ in Lakhs)

    75.45

  • 52 Week High

    34.70

  • 52 Week Low

    12.46

  • Price BSE

    14.0

  • Price NSE

    14.00

  • Market Capital( in Cr.)

    75.45

  • P/C Ratio

    25.80

  • P/E Ratio

    -3.10

  • Price Vs.BV

    -4.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 502.25 410.96 397.71 356.06 329.52 289.03
Excise Duty 492.53 398.89 391.30 352.16 324.12 286.60
Net Sales 502.25 410.96 397.71 356.06 329.52 289.03
Other Income 57.99 11.85 23.55 15.22 15.88 7.30
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 560.24 422.81 421.26 371.28 345.40 296.33
EXPENDITURE :
Raw Materials 492.53 398.89 391.30 352.16 324.12 286.60
Power & Fuel Cost 492.53 398.89 391.30 352.16 324.12 286.60
Employee Cost 78.32 69.15 63.15 55.79 52.53 49.93
Other Manufacturing Expenses 7.14 1.38 24.17 6.78 2.79 10.36
Selling & Administrative Expenses 61.77 56.51 28.95 28.39 29.62 26.23
Miscellaneous Expenses 7.14 1.38 24.17 6.78 2.79 10.36
Less : Pre-operative Expenses Capitalised :
Total Expenditure 543.78 457.35 441.60 399.57 368.46 314.88
Operating Profit 25.33 23.85 25.07 37.20 33.52 31.81
Interest 62.94 59.76 57.16 52.18 28.68 2.62
Gross Profit 16.46 26.04 -19.60 -29.49 -16.66 8.19
Depreciation 27.11 28.67 32.07 32.70 33.59 33.97
Profit Before Tax 16.46 26.04 -19.60 -29.49 -16.66 8.19
Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 14.23 26.04 -20.02 -29.82 -19.12 8.19
Extraordinary Items 16.46 26.04 -19.60 -29.49 -16.66 8.19
Adjusted Net Profit 14.23 26.04 -20.02 -29.82 -19.12 8.19
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 14.23 26.04 -20.02 -29.82 -19.12 8.19
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 2.63 4.81 -3.70 -5.50 -3.53 1.51
Book Value 0.00 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    55.58%

  • Public Share Holding

    44.42%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 17,033,433 31.45 17,033,433 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 13,069,910 24.13 13,069,910 20
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 30,103,343 55.58 30,103,343 21
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 509 0.00 509 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 2,000 0.00 2,000 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2,509 0.00 2,509 3
2] Non Institution
Bodies Corporate 4,780,802 8.83 4,274,302 119
Clearing Members 23,632 0.04 23,632 13
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,341,224 2.48 1,341,224 110
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 750,826 1.39 750,826 396
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,687,664 6.81 3,687,664 12
Individuals holding nominal share capital up to Rs. 1 lakh 12,973,771 23.95 12,794,144 20,256
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 486,683 0.90 486,683 1
Sub Total 24,058,801 44.42 23,372,674 20,912
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 54,164,653 100.00 53,478,526 20,936

Company Background

Ind-Swift LtdPharmaceuticals - Indian - Formulations

  • Ind-Swift Ltd
  • BSE Code : 4123.0
  • ISIN : INE788B01028

  • Incorporation Year

    1986

  • Registered Office

    781 Industrial Area Phase-II
    Ram Darbar, Chandigarh,
    Chandigarh-160002

  • Telephone

    91-0172-2638781-786

  • FAX

    91-0172-2652242

  • Chairman

    S R Mehta

  • Managing Director

    G Munjal

  • Company Secretary

    Puneet Khurana

  • Auditor

    Jain & Associates

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Alankit Assignments Ltd
    Alankit House ,
    4E/2 Jhandewalan Ext,
    Mumbai - New Delhi - 110055

Ind-Swift Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Ind-Swift 13.93 560.24 502.25 1.17 3.39
Abbott India 29,572.60 6,097.18 5,848.91 47.09 44.71
Astrazeneca Phar 8,100.10 1,330.33 1,295.53 208.82 33.26
P & G Health Ltd 5,259.35 1,166.89 1,151.26 36.90 39.76
Glaxosmi. Pharma 2,776.60 3,530.73 3,407.25 55.21 44.44
Cipla 1,452.70 17,645.00 16,574.34 24.90 20.10
Amrutanjan Healt 645.10 437.58 421.23 37.81 20.84
Fermenta Biotec. 292.05 315.24 307.09 27.68 4.10
Guj. Themis Bio. 272.20 174.19 169.82 56.36 44.82
Bliss GVS Pharma 120.00 638.96 605.46 27.46 11.19
Ambalal Sarabhai 37.31 11.70 3.81 15.94 1.92